Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,743
Views
9
CrossRef citations to date
0
Altmetric
Back Matter

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

Alessio Cortellinia Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1209-5735View further author information
ORCID Icon,
Sebastiano Butic Medical Oncology, University Hospital of Parma, Parma, ItalyORCID Iconhttps://orcid.org/0000-0003-0876-0226View further author information
ORCID Icon,
Melissa Bersanellic Medical Oncology, University Hospital of Parma, Parma, Italy;d Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
,
Raffaele Giustie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, ItalyView further author information
,
Fabiana Perronec Medical Oncology, University Hospital of Parma, Parma, ItalyView further author information
,
Pietro Di Marinof Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, ItalyView further author information
,
Nicola Tinarig Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Michele De Tursig Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Antonino Grassadoniag Department of Medical, Oral & Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, ItalyView further author information
,
Katia Cannitaa Medical Oncology, St. Salvatore Hospital, L’Aquila, ItalyView further author information
,
Alessandra Tessitoreb Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Federica Zorattoh Medical Oncology, Santa Maria Goretti Hospital, Latina, ItalyView further author information
,
Enzo Veltrih Medical Oncology, Santa Maria Goretti Hospital, Latina, ItalyView further author information
,
Francesco Malorgioi Medical Oncology, “Santo Spirito” Hospital, Pescara, ItalyView further author information
,
Marco Russanoj Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Cecilia Anesij Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Tea Zeppolaj Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Marco Filettie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, ItalyView further author information
,
Paolo Marchettie U.O.C. Oncologia Medica, Azienda Ospedaliero Universitaria Sant’Andrea, Rome, Italy;k Medical Oncology, Sapienza University of Rome, Rome, Italy;l Medical Oncology (B), Policlinico Umberto I, Rome, Italy;m Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Andrea Botticellik Medical Oncology, Sapienza University of Rome, Rome, ItalyView further author information
,
Gian Carlo Antonini Cappellinim Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Federica De Galitiism Medical Oncology, IDI-IRCCS, Roma, ItalyView further author information
,
Maria Giuseppa Vitalen Medical Oncology, University Hospital of Modena, Modena, ItalyView further author information
,
Francesca Rastellio Medical Oncology, Fermo Area Vasta 4, Fermo, ItalyView further author information
,
Federica Pergolesio Medical Oncology, Fermo Area Vasta 4, Fermo, ItalyView further author information
,
Rossana Berardip Oncology Clinic, Università Politecnica delle Marche, Ancona, ItalyView further author information
,
Silvia Rinaldip Oncology Clinic, Università Politecnica delle Marche, Ancona, ItalyView further author information
,
Marianna Tudiniq Medical Oncology, AV2 Fabriano ASUR Marche, ItalyView further author information
,
Rosa Rita Silvaq Medical Oncology, AV2 Fabriano ASUR Marche, ItalyView further author information
,
Annagrazia Pireddur Medical Oncology Unit, University Hospital of Cagliari, Cagliari, ItalyView further author information
,
Francesco Atzorir Medical Oncology Unit, University Hospital of Cagliari, Cagliari, ItalyView further author information
,
Daniela Iaconos Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, ItalyView further author information
,
Maria Rita Migliorinos Pulmonary Oncology Unit, St. Camillo Forlanini Hospital, Rome, ItalyView further author information
,
Alain Gelibterl Medical Oncology (B), Policlinico Umberto I, Rome, ItalyView further author information
,
Mario Alberto Occhipintil Medical Oncology (B), Policlinico Umberto I, Rome, ItalyView further author information
,
Francesco Martellat Medical Oncology, “G. Mazzini” Hospital, Teramo, ItalyView further author information
,
Alessandro Innou Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, ItalyView further author information
,
Stefania Goriu Medical Oncology Unit, IRCCS, Sacro Cuore Don Calabria Hospital, Verona, ItalyView further author information
,
Sergio Bracardav Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Cristina Zannoriv Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Claudia Mosillov Medical Oncology, Azienda Ospedaliera S. Maria, Terni, ItalyView further author information
,
Alessandro Parisia Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Giampiero Porzioa Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
,
Domenico Mallardow Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, ItalyView further author information
,
Maria Concetta Fargnolib Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;x Dermatology, San Salvatore Hospital, L’Aquila, ItalyView further author information
,
Marcello Tiseoc Medical Oncology, University Hospital of Parma, Parma, Italy;d Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
,
Daniele Santinij Medical Oncology, Campus Bio-Medico University, Rome, ItalyView further author information
,
Paolo A Asciertow Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-8322-475XView further author information
ORCID Icon &
Corrado Ficorellaa Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy;b Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, ItalyView further author information
 show all
Article: 1710389 | Received 05 Oct 2019, Accepted 02 Dec 2019, Published online: 07 Jan 2020

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yaqin Li, Tao Zhou, Xianyi Cheng, Dezhi Li, Meng Zhao & Wei V. Zheng. (2022) microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3. Bioengineered 13:3, pages 4730-4743.
Read now

Articles from other publishers (8)

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica T. Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel L. Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo A. Ascierto, Corrado Ficorella & David J. Pinato. (2023) Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. Clinical Cancer Research 29:14, pages 2714-2724.
Crossref
Ranran Xiao, Jinghan Wu, Brent B. Ward, Huan Liu, Bo Li, Chong Wang, Qiaoshi Xu, Zhengxue Han & Zhien Feng. (2022) Family history of cancer is associated with poorer prognosis in oral squamous cell carcinoma. Oral Diseases 29:5, pages 2066-2075.
Crossref
Alessio Cortellini, Raffaele Giusti, Marco Filetti, Fabrizio Citarella, Vincenzo Adamo, Daniele Santini, Sebastiano Buti, Olga Nigro, Luca Cantini, Massimo Di Maio, Joachim G. J. V. Aerts, Emilio Bria, Federica Bertolini, Miriam Grazia Ferrara, Michele Ghidini, Francesco Grossi, Annalisa Guida, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Lorenzo Antonuzzo, Alain Gelibter, Paolo Marchetti, Rita Chiari, Marianna Macerelli, Francesca Rastelli, Luigi Della Gravara, Stefania Gori, Alessandro Tuzi, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Pecci, Federica Zoratto, Serena Ricciardi, Maria Rita Migliorino, Francesco Passiglia, Giulio Metro, Gian Paolo Spinelli, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio, Marcello Tiseo, Marco Russano, Alessandro Russo & David James Pinato. (2022) High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. Journal of Hematology & Oncology 15:1.
Crossref
Qian Qin, Tomi Jun, Bo Wang, Vaibhav G. Patel, George Mellgard, Xiaobo Zhong, Mahalya Gogerly-Moragoda, Anish B. Parikh, Amanda Leiter, Emily J. Gallagher, Parissa Alerasool, Philip Garcia, Himanshu Joshi, MBBS, Matthew Galsky, William K. Oh & Che-Kai Tsao. (2022) Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discover Oncology 13:1.
Crossref
Marco Russano, Alessio Cortellini, Raffaele Giusti, Alessandro Russo, Federica Zoratto, Francesca Rastelli, Alain Gelibter, Rita Chiari, Olga Nigro, Michele De Tursi, Sergio Bracarda, Stefania Gori, Francesco Grossi, Melissa Bersanelli, Lorenzo Calvetti, Vincenzo Di Noia, Mario Scartozzi, Massimo Di Maio, Paolo Bossi, Alfredo Falcone, Fabrizio Citarella, Francesco Pantano, Corrado Ficorella, Marco Filetti, Vincenzo Adamo, Enzo Veltri, Federica Pergolesi, Mario Alberto Occhipinti, Linda Nicolardi, Alessandro Tuzi, Pietro Di Marino, Serena Macrini, Alessandro Inno, Michele Ghidini, Sebastiano Buti, Giuseppe Aprile, Eleonora Lai, Marco Audisio, Salvatore Intagliata, Riccardo Marconcini, Davide Brocco, Giampiero Porzio, Marta Piras, Erika Rijavec, Francesca Simionato, Clara Natoli, Marcello Tiseo, Bruno Vincenzi, Giuseppe Tonini & Daniele Santini. (2021) Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. Cancer Immunology, Immunotherapy 71:4, pages 865-874.
Crossref
Daniele Santini, Tea Zeppola, Marco Russano, Fabrizio Citarella, Cecilia Anesi, Sebastiano Buti, Marco Tucci, Alessandro Russo, Maria Chiara Sergi, Vincenzo Adamo, Luigia S. Stucci, Melissa Bersanelli, Giulia Mazzaschi, Francesco Spagnolo, Francesca Rastelli, Francesca Chiara Giorgi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Laura Pala, Paola Queirolo, Sergio Bracarda, Serena Macrini, Stefania Gori, Alessandro Inno, Federica Zoratto, Enrica T. Tanda, Domenico Mallardo, Maria Grazia Vitale, Thomas Talbot, Paolo A. Ascierto, David J. Pinato, Corrado Ficorella, Giampiero Porzio & Alessio Cortellini. (2021) PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. Journal of Translational Medicine 19:1.
Crossref
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica Teresa Tanda, Francesco Spagnolo, Francesca Rastelli, Renato Bisonni, Daniele Santini, Marco Russano, Cecilia Anesi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Mario Alberto Occhipinti, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Claudia Bareggi, Olga Nigro, Alessandro Tuzi, Michele De Tursi, Nicola Petragnani, Laura Pala, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Barbara Di Cocco, Domenico Mallardo, Maria Grazia Vitale, David James Pinato, Giampiero Porzio, Corrado Ficorella & Paolo Antonio Ascierto. (2020) Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice. Journal for ImmunoTherapy of Cancer 8:2, pages e001361.
Crossref
Alessandro Parisi, Alessio Cortellini, Olga Venditti, Valentina Santo, Tina Sidoni, Katia Cannita, Corrado Ficorella & Giampiero Porzio. (2020) Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study. Journal of Gastrointestinal Cancer 51:3, pages 1094-1101.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.